1. Inicio
  2. Investigación
  3. Grupos de investigación
  4. Enfermedades Cardiovasculares

Enfermedades Cardiovasculares

Buscador de publicaciones

Sólo se han incluido artículos originales, editoriales y revisiones.

  • Gabani R, Brugaletta S, Bujak K, Pèrez-Vizcayno MJ, Jiménez-Quevedo P, Arévalos V, Muñoz-García E, Trillo-Nouche R, Del Valle R, de la Torre Hernández JM, Salido L, Gutiérrez E, Pan M, Sánchez-Gila J, García Del Blanco B, Moreno R, Blanco Mata R, Oteo JF, Amat-Santos I, Regueiro A, Ten F, Nogales JM, Fernández-Nofrerías E, Andraka L, Ferrer MC, Pinar E, Romaguera R, Cuellas Ramón C, Alfonso F, García-Blas S, Piñero A, Ignasi J, Díaz Mèndez R, Bordes P, Meseguer J, Nombela-Franco L, Sabaté M.

    Impact of gender on in-hospital and long-term outcomes after transcatheter aortic valve implantation: an analysis of the Spanish TAVI registry.

    Revista espanola de cardiologia (English ed.) . : .

    [doi:10.1016/j.rec.2024.08.002]

  • Simonenko M, Hansen D, Niebauer J, Volterrani M, Adamopoulos S, Amarelli C, Ambrosetti M, Anker SD, Bayes-Genis A, Gal TB, Bowen TS, Cacciatore F, Caminiti G, Cavaretta E, Chioncel O, Coats AJS, Cohen-Solal A, D'Ascenzi F, de Pablo Zarzosa C, Gevaert AB, Gustafsson F, Kemps H, Hill L, Jaarsma T, Jankowska E, Joyce E, Krankel N, Lainscak M, Lund LH, Moura B, Nytrøen K, Osto E, Piepoli M, Potena L, Rakisheva A, Rosano G, Savarese G, Seferovic PM, Thompson DR, Thum T, Van Craenenbroeck EM.

    Prevention and rehabilitation after heart transplantation: A clinical consensus statement of the European Association of Preventive Cardiology, Heart Failure Association of the ESC, and the European Cardio Thoracic Transplant Association, a section of ESOT.

    European journal of preventive cardiology . 31(11): 1385-1399.

    [doi:10.1093/eurjpc/zwae179]

  • Gimeno Orna JA, Mañas Martínez AB, Rodríguez Padial L, Anguita Sánchez M, Barrios V, Muñiz García J, Pérez Pérez A.

    Impact of the presence and type of cardiovascular disease on the risk of mortality in type 2 diabetic patients: The DIABET-IC trial.

    ENDOCRINOLOGIA DIABETES Y NUTRICION . 71(7): 278-289.

    [doi:10.1016/j.endien.2024.07.001]

  • Gonzalez-Manzanares R, Anguita-Gámez M, Muñiz J, Barrios V, Gimeno-Orna JA, Pérez A, Rodríguez-Padial L, Anguita M.

    Prevalence and incidence of heart failure in type 2 diabetes patients: results from a nationwide prospective cohort-the DIABET-IC study.

    CARDIOVASCULAR DIABETOLOGY . 23(1): 253-253. Nº de citas: 1

    [doi:10.1186/s12933-024-02358-0]

  • Zamorano JL, González Leal A.

    Advances in heart failure management.

    MEDICINA CLINICA . 163(1): 32-39.

    [doi:10.1016/j.medcli.2023.12.026]

  • Pardo Sanz A, Zamorano Gómez JL.

    How to improve patient outcomes following TAVI in 2024? Recent advances.

    POLISH HEART JOURNAL-KARDIOLOGIA POLSKA . 82(7-8): 696-701. Nº de citas: 1

    [doi:10.33963/v.phj.101399]

  • Ekanem E, Neuzil P, Reichlin T, Kautzner J, van der Voort P, Jais P, Chierchia GB, Bulava A, Blaauw Y, Skala T, Fiala M, Duytschaever M, Szeplaki G, Schmidt B, Massoullie G, Neven K, Thomas O, Vijgen J, Gandjbakhch E, Scherr D, Johannessen A, Keane D, Boveda S, Maury P, García-Bolao I, Anic A, Hansen PS, Raczka F, Lepillier A, Guyomar Y, Gupta D, Van Opstal J, Defaye P, Sticherling C, Sommer P, Kucera P, Osca J, Tabrizi F, Roux A, Gramlich M, Bianchi S, Adragão P, Solimene F, Tondo C, Russo AD, Schreieck J, Luik A, Rana O, Frommeyer G, Anselme F, Kreis I, Rosso R, Metzner A, Geller L, Baldinger SH, Ferrero A, Willems S, Goette A, Mellor G, Mathew S, Szumowski L, Tilz R, Iacopino S, Jacobsen PK, George A, Osmancik P, Spitzer S, Balasubramaniam R, Parwani AS, Deneke T, Glowniak A, Rossillo A, Pürerfellner H, Duncker D, Reil P, Arentz T, Steven D, Olalla JJ, de Jong JSSG, Wakili R, Abbey S, Timo G, Asso A, Wong T, Pierre B, Ewertsen NC, Bergau L, Lozano-Granero C, Rivero M, Breitenstein A, Inkovaara J, Fareh S, Latcu DG, Linz D, Müller P, Ramos-Maqueda J, Beiert T, Themistoclakis S, Meininghaus DG, Stix G, Tzeis S, Baran J, Almroth H, Munoz DR, de Sousa J, Efremidis M, Balsam P, Petru J, Küffer T, Peichl P, Dekker L, Della Rocca DG, Moravec O, Funasako M, Knecht S, Jauvert G, Chun J, Eschalier R, Füting A, Zhao A, Koopman P, Laredo M, Manninger M, Hansen J, O'Hare D, Rollin A, Jurisic Z, Fink T, Chaumont C, Rillig A, Gunawerdene M, Martin C, Kirstein B, Nentwich K, Lehrmann H, Sultan A, Bohnen J, Turagam MK, Reddy VY.

    Safety of pulsed field ablation in more than 17,000 patients with atrial fibrillation in the MANIFEST-17K study.

    NATURE MEDICINE . 30(7): 2020-2029. Nº de citas: 19

    [doi:10.1038/s41591-024-03114-3]

  • Gulizia MM, Turazza FM, Ameri P, Alings M, Collins R, De Luca L, Di Nisio M, Lucci D, Gabrielli D, Janssens S, Parrini I, Pinto FJ, Zamorano J, Colivicchi F.

    Characteristics and Management of Patients With Cancer and Atrial Fibrillation: The BLITZ-AF Cancer Registry.

    Jacc. Advances . 3(7): 100991-100991. Nº de citas: 1

    [doi:10.1016/j.jacadv.2024.100991]

  • Tesoro L, Hernandez I, Saura M, Badimón L, Zaragoza C.

    Novel cutting edge nano-strategies to address old long-standing complications in cardiovascular diseases. A comprehensive review.

    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION . 54(7): .

    [doi:10.1111/eci.14208]

  • Piris A, Garcia-Linacero LM, Ortega-Perez R, Rivas-Garcia S, Martinez-Moya R, Sanmartin M, Zamorano JL.

    Safety of an Early Discharge Strategy (=48 h) after ST-Elevation Myocardial Infarction.

    Journal Of Clinical Medicine . 13(13): .

    [doi:10.3390/jcm13133827]

  • Dreyfus J, Taramasso M, Kresoja KP, Omran H, Iliadis C, Russo G, Weber M, Nombela-Franco L, Estevez Loureiro R, Hausleiter J, Latib A, Stolz L, Praz F, Windecker S, Zamorano JL, von Bardeleben RS, Tang GHL, Hahn R, Lubos E, Webb J, Schofer J, Fam N, Lauten A, Pedrazzini G, Rodés-Cabau J, Nejjari M, Badano L, Alessandrini H, Himbert D, Sievert H, Piayda K, Donal E, Modine T, Nickenig G, Pfister R, Rudolph V, Bernick J, Wells GA, Bax J, Lurz P, Enriquez-Sarano M, Maisano F, Messika-Zeitoun D.

    Prognostic Implications of Residual Tricuspid Regurgitation Grading After Transcatheter Tricuspid Valve Repair.

    JACC-CARDIOVASCULAR INTERVENTIONS . 17(12): 1485-1495. Nº de citas: 13

    [doi:10.1016/j.jcin.2024.04.023]

  • Simonenko M, Hansen D, Niebauer J, Volterrani M, Adamopoulos S, Amarelli C, Ambrosetti M, Anker SD, Bayes-Genis A, Ben Gal T, Bowen TS, Cacciatore F, Caminiti G, Cavarretta E, Chioncel O, Coats AJS, Cohen-Solal A, D'Ascenzi F, de Pablo Zarzosa C, Gevaert AB, Gustafsson F, Kemps H, Hill L, Jaarsma T, Jankowska E, Joyce E, Krankel N, Lainscak M, Lund LH, Moura B, Nytrøen K, Osto E, Piepoli M, Potena L, Rakisheva A, Rosano G, Savarese G, Seferovic PM, Thompson DR, Thum T, Van Craenenbroeck EM.

    Prevention and Rehabilitation After Heart Transplantation: A Clinical Consensus Statement of the European Association of Preventive Cardiology, Heart Failure Association of the ESC, and the European Cardio Thoracic Transplant Association, a Section of ESOT.

    TRANSPLANT INTERNATIONAL . 37: 13191-13191.

    [doi:10.3389/ti.2024.13191]

  • Tirado-Conte G, Sánchez-Recalde Á, Zamorano JL.

    Is DOAC the preferred oral anticoagulation therapy after TAVI?

    Revista espanola de cardiologia (English ed.) . 77(12): 985-986.

    [doi:10.1016/j.rec.2024.06.001]

  • Nikolova, Andriana, Agbor-Enoh, Sean, Bos, Saskia, Crespo-Leiro, Marisa, Ensminger, Stephan, Jimenez-Blanco, Marta, Minervini, Annamaria, Perch, Michael, Segovia, Javier, Vos, Robin, Khush, Kiran, Potena, Luciano.

    European Society for Organ Transplantation (ESOT) Consensus Statement on the Use of Non-invasive Biomarkers for Cardiothoracic Transplant Rejection Surveillance

    TRANSPLANT INTERNATIONAL . 37: 12445-12445.

    [doi:10.3389/ti.2024.12445]

  • Anker SD, Friede T, von Bardeleben RS, Butler J, Khan MS, Diek M, Heinrich J, Geyer M, Placzek M, Ferrari R, Abraham WT, Alfieri O, Auricchio A, Bayes-Genis A, Cleland JGF, Filippatos G, Gustafsson F, Haverkamp W, Kelm M, Kuck KH, Landmesser U, Maggioni AP, Metra M, Ninios V, Petrie MC, Rassaf T, Ruschitzka F, Schäfer U, Schulze PC, Spargias K, Vahanian A, Zamorano JL, Zeiher A, Karakas M, Koehler F, Lainscak M, Öner A, Mezilis N, Theofilogiannakos EK, Ninios I, Chrissoheris M, Kourkoveli P, Papadopoulos K, Smolka G, Wojakowski W, Reczuch K, Pinto FJ, Zmudka K, Kalarus Z, Adamo M, Santiago-Vacas E, Ruf TF, Gross M, Tongers J, Hasenfuß G, Schillinger W, Ponikowski P.

    Percutaneous repair of moderate-to-severe or severe functional mitral regurgitation in patients with symptomatic heart failure: Baseline characteristics of patients in the RESHAPE-HF2 trial and comparison to COAPT and MITRA-FR trials.

    EUROPEAN JOURNAL OF HEART FAILURE . 26(7): 1608-1615. Nº de citas: 6

    [doi:10.1002/ejhf.3286]

  • Arrarte Esteban V, Campuzano Ruiz R, de Pablo Zarzosa C, Fernández Olmo MR.

    The state of cardiac rehabilitation in Spain. Results of the AULARC registry.

    Revista espanola de cardiologia (English ed.) . 77(9): 796-798.

    [doi:10.1016/j.rec.2024.04.014]

  • Tonko JB, Lozano C, Moreno J, Chow A, Dhinoja M, Lambiase PD.

    Near Field Detection and Peak Frequency Metric for Substrate and Activation Mapping of Ventricular Arrhythmias in 2- and 3-Dimensional Circuits.

    EUROPACE . 26(7): . Nº de citas: 1

    [doi:10.1093/europace/euae154]

  • Jiménez-Blanco Bravo M, Alonso Salinas GL, Parra Esteban C, Toquero Ramos J, Amores Luque M, Zamorano Gómez JL, García-Izquierdo E, Álvarez-García J, Fernández Lozano I, Castro Urda V.

    Right Bundle Branch Block Predicts Appropriate Implantable Cardioverter Defibrillator Therapies in Patients with Non-Ischemic Dilated Cardiomyopathy and a Prophylactic Implantable Cardioverter Defibrillator.

    DIAGNOSTICS . 14(11): .

    [doi:10.3390/diagnostics14111173]